rs606443
Variant names: 
Your query was ambiguous. Multiple possible variants found: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000706469.1(SRSF9):c.89+1809G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.729 in 152,070 control chromosomes in the GnomAD database, including 41,496 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.73   (  41496   hom.,  cov: 31) 
Consequence
 SRSF9
ENST00000706469.1 intron
ENST00000706469.1 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.0740  
Publications
15 publications found 
Genes affected
 SRSF9  (HGNC:10791):  (serine and arginine rich splicing factor 9) The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two pseudogenes, one on chromosome 15 and the other on chromosome 21, have been found for this gene. [provided by RefSeq, Sep 2010] 
 DYNLL1  (HGNC:15476):  (dynein light chain LC8-type 1) Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. The protein described in this record is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.901  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SRSF9 | ENST00000706469.1  | c.89+1809G>T | intron_variant | Intron 1 of 3 | ENSP00000516402.1 | |||||
| DYNLL1 | ENST00000392509.6  | c.-7+2723C>A | intron_variant | Intron 1 of 2 | 3 | ENSP00000376297.2 | ||||
| DYNLL1 | ENST00000548342.5  | c.-144+2723C>A | intron_variant | Intron 1 of 4 | 2 | ENSP00000447907.1 | 
Frequencies
GnomAD3 genomes   AF:  0.728  AC: 110692AN: 151952Hom.:  41442  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
110692
AN: 
151952
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.729  AC: 110804AN: 152070Hom.:  41496  Cov.: 31 AF XY:  0.729  AC XY: 54141AN XY: 74310 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
110804
AN: 
152070
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
54141
AN XY: 
74310
show subpopulations 
African (AFR) 
 AF: 
AC: 
37711
AN: 
41518
American (AMR) 
 AF: 
AC: 
9312
AN: 
15260
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2506
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3770
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
3281
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
7269
AN: 
10548
Middle Eastern (MID) 
 AF: 
AC: 
187
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
44815
AN: 
67956
Other (OTH) 
 AF: 
AC: 
1390
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1456 
 2912 
 4368 
 5824 
 7280 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 826 
 1652 
 2478 
 3304 
 4130 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2471
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.